查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948160

2034年全球類器官與球狀體市場機會與策略

Organoids And Spheroids Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 355 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

全球類器官和球狀體市場預計到2024年將達到約11.5946億美元，自2019年以來年複合成長率為20.38%。預計該市場將從2024年的11.5946億美元成長到2029年的28.672億美元，年複合成長率為19.85%。之後，預計從2029年起將繼續以19.34%的年複合成長率成長，到2034年達到69.3947億美元。

類器官和球狀體是3D（3D）細胞培養模型，旨在體外忠實重現人體組織和器官的結構、功能和微環境。球狀體是簡單的球形細胞叢集，能夠自組織複製基本的組織結構；而類器官則是更為複雜的幹細胞衍生3D結構，能夠模擬特定的器官功能和細胞多樣性。這些模型來自幹細胞、原代組織或癌細胞，並在受控環境下培養時自組織成複雜的類組織結構。

對個人化和精準醫療的需求日益成長

過去，對個人化和精準醫療日益成長的需求推動了類器官和球狀體市場的發展。這些3D細胞培養模型能夠忠實地複製人體組織的結構和功能，從而實現更精確的疾病建模、藥物篩檢和針對個別患者的治療方法測試。製藥和生物技術公司正擴大採用類器官和球狀體來開發標靶治療、降低臨床試驗失敗率並加速研發進程。隨著人們越來越關注患者特異性治療方法和客製化醫療解決方案，這些先進模型的應用已成為精準醫療領域不可或缺的工具，並促進了市場的強勁成長。例如，根據美國非營利組織個人化醫療聯盟（Personalized Medicine Coalition）的數據顯示，截至2024年2月，美國食品藥物管理局（FDA）在2023年核准了16種用於治療罕見疾病的個人化治療方法，高於2022年的6核准。因此，對個人化和精準醫療日益成長的需求推動了類器官和球狀體市場的成長。

創新的滲透性培養技術提高了3D細胞生長和體外建模效率

在類器官和球狀體市場中，主要企業正致力於開發先進的培養平台和材料，以增強細胞活力和氧氣輸送，從而提高藥物研發、再生醫學和個人化治療等應用領域體外模型的準確性和擴充性。例如，2025年6月，日本化學品製造商三井化學集團推出了滲透性細胞培養微孔盤「InnoCell」。這款創新微孔盤結合了該公司特有的材料和精密切割技術，能夠增強細胞氧氣輸送，減少細胞死亡，並提高細胞長期存活率，尤其是在3D球狀體和類器官培養中。本產品有兩種類型：未處理型（N型）和膠原蛋白包被型（C型），以適應多種細胞類型。此外，它還具有低藥物吸附和優異的螢光成像性能。這些優勢使該產品能夠為藥物研發、個人化醫療、再生醫學和藥物研究中的先進體外建模提供支援。

全球類器官和球狀體市場是一個相對集中的市場，主要由大型企業參與。截至2024年，排名前十的主要企業將佔據31.03%的市場。

目錄

第1章執行摘要

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章 市場特徵

  • 一般市場定義
  • 概述
  • 類器官和球狀體市場定義和細分
  • 按類型分類的市場細分
    • 類器官
    • 球狀體
  • 依方法進行市場區隔
    • 細胞外基質支架
    • 旋轉生物反應器法
    • 懸滴法
    • 低黏附性培養板法
    • 磁浮
    • 其他方法
  • 市場區隔：按應用
    • 發育生物學
    • 個人化醫療
    • 再生醫學
    • 疾病病理學研究
    • 藥物毒性和療效測試
  • 市場區隔：依最終用戶分類
    • 生物技術和製藥業
    • 學術研究機構
    • 醫院和診斷中心

第7章：主要市場趨勢

  • 創新的滲透性培養技術提高了3D細胞生長和體外建模效率
  • 血管化類器官工程為再生醫學和疾病建模開闢了新途徑
  • 可擴展功能性肝臟類器官的突破性進展推動了再生醫學和藥物測試應用的發展。
  • 人工智慧整合的心臟類器官創新提升藥物安全性和精準醫療
  • 整合式3D細胞培養技術加速了再生醫學和生物製藥研究的進展

8. 類器官和球狀體的生長分析和策略分析框架

  • 全球類器官和球狀體市場的PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
    • 政治因素
    • 經濟
    • 社會的
    • 技術的
    • 環境
    • 合法的
  • 終端用戶（B2B）市場分析
    • 生物技術和製藥業
    • 學術研究機構
    • 醫院和診斷中心
  • 類器官和球狀體市場：成長率分析
  • 2019-2024年全球市場成長表現
    • 2019-2024年市場促進因素
    • 2019-2024年市場限制
  • 全球市場成長預測，2024-2029年，2034年預測
  • 預期成長要素/促進因素
    • 定量成長要素
    • 促進要素
    • 抑制因素
  • 全球類器官和球狀體總潛在市場（TAM）

9. 類器官和球狀體市場細分

  • 全球類器官與球狀體市場：依類型、表現及預測分類，2019-2024年、2029年預測、2034年預測
  • 全球類器官與球狀體市場：依方法、表現及預測分類，2019-2024年、2029年預測、2034年預測
  • 全球類器官和球狀體市場：按應用、性能和預測分類，2019-2024年、2029年預測、2034年預測
  • 全球類器官與球狀體市場：依最終使用者、表現及預測分類，2019-2024年、2029年預測、2034年預測
  • 全球類器官和球狀體市場：按類器官、類型、表現和預測細分，2019-2024年、2029年預測、2034年預測
  • 全球類器官與球狀體市場：依球狀體類型、表現及預測細分，2019-2024年、2029年預測、2034年預測

第10章 類器官和球狀體市場：區域和國家分析

  • 類器官及球狀體市場：區域表現及預測，2019-2024年、2029年預測、2034年預測
  • 類器官與球狀體市場：國家、表現與預測，2019-2024年、2029年預測、2034年預測

第11章 亞太市場

第12章 西歐市場

第13章 東歐市場

第14章 北美市場

第15章：南美市場

第16章 中東市場

第17章：非洲市場

第18章：競爭格局與公司概況

  • 公司簡介
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA（Hubrecht Organoid Technology（HUB））
  • Lonza Group AG
  • STEMCELL Technologies Inc

第19章：其他領先和創新企業

  • Molecular Devices LLC
  • Cellink（BICO Group）
  • American Type Culture Collection（ATCC）
  • BioIVT
  • InSphero AG
  • Cellesce Ltd.
  • Crown Bioscience Inc.
  • 3D Biomatrix Inc.
  • Mimetas BV
  • 3D Biotek LLC
  • AxoSim Technologies
  • DefiniGEN Limited
  • Prellis Biologics Inc.
  • Revivocell Ltd.
  • Visikol Inc.

第20章：競爭標竿分析

第21章 競爭格局分析

第22章 重大併購

  • Merck Group Strengthens Next-Generation Biology Capabilities Through Hub Organoids Acquisition

第23章 近期趨勢

  • 標準化類器官模型建構舉措：推進人工智慧驅動的藥物發現並減少動物試驗
  • 引進先進的3D灌注培養系統，以提高精準醫療和藥物篩檢效率
  • 石墨烯基光刺激技術的突破加速了腦類器官的發育與神經生物混合研究
  • 先進的基於3D類器官的藥物篩檢平台增強精準醫療並加速藥物研發

第24章：機遇與策略

  • 2029年類器官和球狀體市場－最具新興機會的國家
  • 2029年類器官和球狀體市場－最具新興機會的細分市場
  • 類器官與球狀體市場成長策略展望至2029年
    • 基於市場趨勢的策略
    • 競爭對手策略

第25章 類器官和球狀體市場：結論與建議

  • 結論
  • 建議

第26章附錄

簡介目錄
Product Code: HS4MOSPH01_O25Q4

Organoids and spheroids refer to three-dimensional (3D) cell culture models developed to closely mimic the architecture, function, and microenvironment of human tissues and organs in vitro. Spheroids are simple, spherical clusters of cells that self-assemble and replicate basic tissue organization, while organoids are more complex, stem cell-derived 3D structures that recreate specific organ functions and cellular diversity. These models are derived from stem cells, primary tissues, or cancer cells and are cultivated in a controlled environment that allows them to self-organize into complex tissue-like structures.

The global organoids and spheroids market reached a value of nearly $1,159.46 million in 2024, having grown at a compound annual growth rate (CAGR) of 20.38% since 2019. The market is expected to grow from $1,159.46 million in 2024 to $2,867.20 million in 2029 at a rate of 19.85%. The market is then expected to grow at a CAGR of 19.34% from 2029 and reach $6,939.47 million in 2034.

Rising Demand For Personalized And Precision Medicine

The rising demand for personalized and precision medicine supported the growth of the organoids and spheroids market in the historic period. These three-dimensional cell culture models closely replicate human tissue architecture and function, enabling more accurate disease modeling, drug screening, and therapeutic testing tailored to individual patients. Pharmaceutical and biotechnology companies increasingly adopted organoids and spheroids to develop targeted treatments, reduce clinical trial failures, and accelerate research and development timelines. The growing focus on patient-specific therapies and customized healthcare solutions fueled the adoption of these advanced models, positioning them as essential tools in precision medicine and contributing to the market's robust expansion. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the United States Food and Drug Administration granted approval for 16 personalized therapies in 2023 aimed at treating rare diseases, marking a rise from the six such treatments approved in 2022. Therefore, the rising demand for personalized and precision medicine drove the growth of the organoids and spheroids market.

Innovative Oxygen-Permeable Culture Technology Enhances 3D Cell Growth And In Vitro Modeling Efficiency

Major companies operating in the organoids and spheroids market are focusing on developing advanced culture platforms and materials that enhance cell viability and oxygen delivery to improve the accuracy and scalability of in vitro models for drug discovery, regenerative medicine, and personalized therapy applications. For instance, in June 2025, Mitsui Chemicals Group, a Japan-based chemical manufacturing company, has introduced its InnoCell oxygen-permeable cell culture microplates. These novel microplates combine the company's specialized materials and precision cutting techniques to enhance oxygen delivery to cells, especially useful in 3D spheroid and organoid cultures, reducing cell death and improving long-term viability. They come in both non-treated (N-type) and collagen-coated (C-type) versions for diverse cell types. The plates also feature low drug adsorption and excellent fluorescence imaging properties. With these advancements, the product is positioned to support drug discovery, personalized medicine, regenerative therapies, and advanced in vitro modeling in pharmaceutical research.

The global organoids and spheroids market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 31.03% of the total market in 2024.

Organoids And Spheroids Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids and spheroids market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for organoids and spheroids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids and spheroids market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids and spheroids market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by method, by application and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by method, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Recent Developments Information on recent developments in the market covered in the report.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for organoids and spheroids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Organoids; Spheroids
  • 2) By Method: Extracellular Matrix Scaffold Method; Spinning Bioreactor Method; Hanging Drop Method; Low Adherent Culture Plate Method; Magnetic Levitation Method; Other Methods
  • 3) By Application: Developmental Biology; Personalized Medicine; Regenerative Medicine; Disease Pathology Studies; Drug Toxicity And Efficacy Testing
  • 4) By End-User: Biotechnology And Pharmaceutical Industry; Academic And Research Institutes; Hospitals And Diagnostic Centers
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Corning Incorporated; Merck KGaA (Hubrecht Organoid Technology (HUB)); Lonza Group AG; StemCell Technologies Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids and spheroids indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Organoids And Spheroids - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Organoids And Spheroids Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Organoids
    • 6.4.2 Spheroids
  • 6.5 Market Segmentation By Method
    • 6.5.1 Extracellular Matrix Scaffold Method
    • 6.5.2 Spinning Bioreactor Method
    • 6.5.3 Hanging Drop Method
    • 6.5.4 Low Adherent Culture Plate Method
    • 6.5.5 Magnetic Levitation Method
    • 6.5.6 Other Methods
  • 6.6 Market Segmentation By Application
    • 6.6.1 Developmental Biology
    • 6.6.2 Personalized Medicine
    • 6.6.3 Regenerative Medicine
    • 6.6.4 Disease Pathology Studies
    • 6.6.5 Drug Toxicity and Efficacy Testing
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Biotechnology and Pharmaceutical Industry
    • 6.7.2 Academic and Research Institutes
    • 6.7.3 Hospitals and Diagnostic Centers

7 Major Market Trends

  • 7.1 Innovative Oxygen-Permeable Culture Technology Enhances 3D Cell Growth And In Vitro Modeling Efficiency
  • 7.2 Vascularized Organoid Engineering Opens New Pathways For Regenerative Medicine And Disease Modeling
  • 7.3 Scalable Functional Liver Organoid Breakthrough Advances Regenerative Medicine And Drug Testing Applications
  • 7.4 AI-Integrated Cardiac Organoid Innovation Enhances Drug Safety And Precision Medicine
  • 7.5 Integrated 3D Cell Culture Technologies Accelerate Advances In Regenerative Medicine And Biopharma Research

8 Organoids And Spheroids Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Organoids And Spheroids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End User (B2B) Market
    • 8.2.1 Biotechnology And Pharmaceutical Industry
    • 8.2.2 Academic And Research Institutes
    • 8.2.3 Hospitals And Diagnostic Centers
  • 8.3 Organoids And Spheroids Market Growth Rate Analysis
  • 8.4 Global Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Global Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Organoids And Spheroids Total Addressable Market (TAM)

9 Organoids And Spheroids Market Segmentation

  • 9.1 Global Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Organoids And Spheroids Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Organoids And Spheroids Market, Sub-Segmentation Of Organoids, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Organoids And Spheroids Market, Sub-Segmentation Of Spheroids, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Organoids And Spheroids Market, Regional and Country Analysis

  • 10.1 Organoids And Spheroids Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Organoids And Spheroids Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia-Pacific Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia-Pacific Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia-Pacific Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 China Market
  • 11.7 Summary
  • 11.8 Market Overview
    • 11.8.1 Country Information
    • 11.8.2 Market Information
    • 11.8.3 Background Information
    • 11.8.4 Government Initiatives
    • 11.8.5 Regulations
    • 11.8.6 Regulatory Bodies
    • 11.8.7 Major Associations
    • 11.8.8 Taxes Levied
    • 11.8.9 Corporate Tax Structure
    • 11.8.10 Investments
    • 11.8.11 Major Companies
  • 11.9 China Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.10 China Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 India Market
  • 11.13 India Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.14 India Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 Japan Market
  • 11.17 Summary
  • 11.18 Market Overview
    • 11.18.1 Country Information
    • 11.18.2 Market Information
    • 11.18.3 Background Information
    • 11.18.4 Government Initiatives
    • 11.18.5 Regulations
    • 11.18.6 Regulatory Bodies
    • 11.18.7 Major Associations
    • 11.18.8 Taxes Levied
    • 11.18.9 Corporate Tax Structure
    • 11.18.10 Investments
    • 11.18.11 Major Companies
  • 11.19 Japan Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.20 Japan Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Australia Market
  • 11.23 Australia Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.24 Australia Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Indonesia Market
  • 11.27 Indonesia Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.28 Indonesia Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 South Korea Market
  • 11.31 Summary
  • 11.32 Market Overview
    • 11.32.1 Country Information
    • 11.32.2 Market Information
    • 11.32.3 Background Information
    • 11.32.4 Government Initiatives
    • 11.32.5 Regulations
    • 11.32.6 Regulatory Bodies
    • 11.32.7 Major Associations
    • 11.32.8 Taxes Levied
    • 11.32.9 Corporate Tax Structure
    • 11.32.10 Investments
    • 11.32.11 Major Companies
  • 11.33 South Korea Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.34 South Korea Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Organoids And Spheroids Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major companies
  • 13.3 Eastern Europe Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Organoids And Spheroids Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Organoids And Spheroids Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Major Companies
  • 14.16 Canada Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Major Companies
  • 15.3 South America Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Organoids And Spheroids Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 Middle East Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Africa Organoids And Spheroids Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Organoids And Spheroids Market, Segmentation By Method, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Organoids And Spheroids Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Thermo Fisher Scientific Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Corning Inc
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Merck KGaA (Hubrecht Organoid Technology (HUB))
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Financial Overview
  • 18.5 Lonza Group AG
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 STEMCELL Technologies Inc
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Molecular Devices LLC
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 Cellink (BICO Group)
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 American Type Culture Collection (ATCC)
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 BioIVT
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 InSphero AG
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Cellesce Ltd.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Crown Bioscience Inc.
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 3D Biomatrix Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Mimetas B.V.
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 3D Biotek LLC
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 AxoSim Technologies
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 DefiniGEN Limited
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Prellis Biologics Inc.
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Revivocell Ltd.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Visikol Inc.
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Merck Group Strengthens Next-Generation Biology Capabilities Through Hub Organoids Acquisition

23 Recent Development

  • 23.1 Standardized Organoid Modeling Initiative To Advance AI-Driven Drug Discovery And Reduce Animal Testing
  • 23.2 Advanced 3D Perfusion Culture System Introduced To Enhance Precision Medicine And Drug Screening Efficiency
  • 23.3 Graphene-Based Optical Stimulation Breakthrough Accelerates Brain Organoid Development And Neuro-Biohybrid Research
  • 23.4 Advanced 3D Organoid-Based Drug Screening Platform Enhances Precision Medicine And Accelerates Drug Development

24 Opportunities And Strategies

  • 24.1 Organoids And Spheroids Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Organoids And Spheroids Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Organoids And Spheroids Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Organoids And Spheroids Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer